Expertise in
14
conditions

Dr. Zoe D. Draelos

High Point, NC
Expertise in
14
conditions
Specialties:Dermatology
Expertise in
14
conditions
OverviewInsuranceLocationsClinical Research

Overview

Zoe Draelos is a Dermatologist in High Point, North Carolina. Dr. Draelos is highly rated in 14 conditions, according to our data. Her top areas of expertise are Acne, Rosacea, Pustules, and Atopic Dermatitis.

Her clinical research consists of co-authoring 259 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in NC
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

2444 N Main St, High Point, NC 27262
336-841-2040

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
Enrollment Status: Completed
Publish Date: September 07, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
Enrollment Status: Completed
Publish Date: December 16, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Single-center, Placebo Controlled Study to Investigate the Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
A Single-center, Placebo Controlled Study to Investigate the Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
Enrollment Status: Completed
Publish Date: July 09, 2020
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Enrollment Status: Completed
Publish Date: April 02, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
Enrollment Status: Completed
Publish Date: June 21, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 11 Less Clinical Trials

259 Total Publications

Effective With Minimal Side Effects: A Novel Treatment Regimen for Acne Vulgaris Using Multifunctional Ingredients.
Effective With Minimal Side Effects: A Novel Treatment Regimen for Acne Vulgaris Using Multifunctional Ingredients.
Journal: Journal of drugs in dermatology : JDD
Published: December 04, 2024
Similar Doctors
Steven R. Feldman
Expertise in
54
conditions
Dr. Steven R. Feldman
Dermatology
Expertise in
54
conditions
Dr. Steven R. Feldman
Dermatology

Wake Forest University Health Sciences

Medical Ctr Blvd, 
Winston Salem, NC 
 (15.4 mi)
336-716-2734
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Feldman is a Dermatologist in Winston Salem, North Carolina. Dr. Feldman is highly rated in 54 conditions, according to our data. His top areas of expertise are Psoriasis, Acne, Plaque Psoriasis, Rosacea, and Septoplasty. Dr. Feldman is currently accepting new patients.

Expertise in
40
conditions
Dr. Amy J. Mcmichael
Dermatology
Expertise in
40
conditions
Dr. Amy J. Mcmichael
Dermatology

Wake Forest University Health Sciences

1200 N Martin Luther King Jr Dr, 
Winston Salem, NC 
 (14.4 mi)
336-713-9800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amy Mcmichael is a Dermatologist in Winston Salem, North Carolina. Dr. Mcmichael is highly rated in 40 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Graham-Little-Piccardi-Lassueur Syndrome, and GAPO Syndrome. Dr. Mcmichael is currently accepting new patients.

Expertise in
182
conditions
Dr. Joseph L. Jorizzo
Dermatology
Expertise in
182
conditions
Dr. Joseph L. Jorizzo
Dermatology

Wake Forest University Health Sciences

4610 Country Club Rd, 
Winston Salem, NC 
 (18.3 mi)
336-716-2255
Languages Spoken:
English
See accepted insurances
Accepting New Patients

My passion throughout my career in dermatology has been to care for adult and pediatric patients with complex medical dermatology problems. My research and publications focus on dermatologic manifestations of internal medical diseases. I also care for patients with common dermatologic problems of skin, hair, nails, and mucous membranes. Dr. Jorizzo is highly rated in 182 conditions, according to our data. His top areas of expertise are Pyoderma Gangrenosum, Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), and Lichen Planus.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile